BME50 - A USC Viterbi bioengineer is building digital tumors, cell by cell, with a goal that could change how oncologists treat breast cancer: knowing in advance which patients immunotherapy will ...

“On our Cancer-Free World Podcast, Daniel Stover, explains how his Ohio State team uses digital pathology, liquid biopsy and other high-tech tools to improve outcomes for today’s cancer patients while ...

The tumors, test results, and treatments I present to future physicians? Mine,” writes David Elkowitz, a professor of ...

In a report published in The New England Journal of Medicine, researchers document a case of complete regression of ...

Cancer rates are rising in adults under 55, and new research suggests accelerated biological aging may be one piece of the puzzle. Scientists found that people from more recent generations tended to ...

"I was given more financial grace to have my son than when I needed leave because I had cancer," the mom told Newsweek.

Daniel Zhang is the 17-year-old co-creator of Tumor Tactics, a card strategy game that aims to demystify cancer for kids by ...

The star is making a stage comeback in Paris this weekend, after six years battling a rare neurological condition ...

A patient with advanced, treatment-resistant lung cancer became tumor-free after treatment with the selenium compound selenite. This is shown in a new study from Karolinska University Hospital and ...

An experimental skin cancer vaccine significantly reduced the risk of melanoma returning or spreading in a late-stage clinical trial from Merck and Moderna. The results mark the first positive Phase 3 ...

Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients. By Carolyn Y. Johnson An experimental mRNA vaccine allowed people with high ...

Stephane Bancel, Moderna CEO, and Dr. Dean Li, Merck Research Laboratories president, join 'Squawk Box' to discuss details of an experimental personalized cancer vaccine that showed positive initial ...